Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

Loss of may let create that drive

In older-donor , loss may expose surviving to that create -causing . Failure to show increased exposure, surviving new or their in would bound this in the tested setting

Omega Point 1.5

Stage of verification

  1. Hypothesis published2026-10-10
  2. Indirect evidenceAssessed at 4 of 10
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionGut and microbiome

Biological function

Resident epithelial cells contribute to a functional mucosal barrier that limits exposure of surviving renewing cells to microbial genotoxins when an active toxin-producing microorganism is present. This protective contribution requires functional evidence; apparent epithelial coverage alone does not establish it.Barrier protection against genotoxic exposure

Direction

Lens

Puts the cause outside the part under study, in the wider system and the conditions it sits in.System and environment

Kind of knowledge gap

Established results make incompatible predictions.Clash gap

A double ring marks the main placement where a group contains several values.

Goal
Закрепление возрастных повреждений через преимущество дефектного обновления
Competing hypotheses
3
Published
2026-10-10
Engine version
Omega Point 1.5
As a hypothesis
10 / 10Clarity of mechanism
10 / 10Few extra conditions
6 / 10Completeness of the answer
5 / 10Novelty of the idea
10 / 10Few new entities
9 / 10Decisive experiment
2 / 10Silver-bullet potential
4 / 10Support from research

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Metabolite or ion

    Genotoxic

    Microbially produced substances that can damage genetic material in exposed cells

    Where this hypothesis actsOlder-donor with verified active production during repair

    Hypotheses on this target 1
    Genotoxic microbial toxinsSupplementation. Hypotheses on this target 0Accelerated excretion. Hypotheses on this target 0Composition restoration. Hypotheses on this target 0
    • Supplementation
    • Accelerated excretion
    • Composition restoration

    What is proposed

    Interrupt activity to test its contribution to newly acquired

    With whatControlled genetic model

    HowCompare verified , and producer conditions, validating microbial ecology and

    Possible result

    Possible reduction in whose newly causally contribute to sustained

    From the recordspecific toxin interruption reduces the acquired-lesion-mediated component

  2. Specialised cell of an organ

    Cells that form tissue

    Where this hypothesis acts in older-donor undergoing repeated repair

    Hypotheses on this target 3
    Epithelial cellsFunction restoration. Hypotheses on this target 0Reprogramming. Hypotheses on this target 0Transplantation. Hypotheses on this target 0Elimination. Hypotheses on this target 22Proliferation. Hypotheses on this target 0
    • Function restoration
    • Reprogramming
    • Transplantation
    • Elimination2
    • Proliferation

    What is proposed

    Elimination

    Remove a limited area of cells to test their protective contribution

    With whatPhysical or surgical intervention

    HowCompare controlled small-area removal with and , matching initial injury and testing

    Possible result

    Possible increased exposure and new if removal disrupts functional protection

    From the recordCross retention, viability-preserving suppression and controlled small-area removal

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesInterleukin-11. Hypotheses on this target 5Interleukin-11Antibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHeme-associated iron. Hypotheses on this target 1Heme-associated ironHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNTGenotoxic microbial toxins. Hypotheses on this target 1Genotoxic microbial toxins
GenesRetroelements. Hypotheses on this target 3RetroelementsExtrachromosomal DNA. Hypotheses on this target 2Extrachromosomal DNAAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesGenomic alterations. Hypotheses on this target 1Genomic alterationsHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p300PCMT1. Hypotheses on this target 2PCMT1TIM-4. Hypotheses on this target 2TIM-412-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIContractile proteins. Hypotheses on this target 1Contractile proteinsDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenasegp130. Hypotheses on this target 1gp130HCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2IL-11 receptor alpha. Hypotheses on this target 1IL-11 receptor alphaInterleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsT cells. Hypotheses on this target 4T cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueDamaged cells. Hypotheses on this target 2Damaged cellsMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsApoptotic bodies. Hypotheses on this target 1Apoptotic bodiesBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsEpithelial cells. Hypotheses on this target 3Epithelial cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkConnective tissue. Hypotheses on this target 2Connective tissueSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCell-surface macromolecular brush. Hypotheses on this target 1Cell-surface macromolecular brushCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsMuscle fiber architecture. Hypotheses on this target 1Muscle fiber architectureSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 9EfferocytosisEpithelial barrier repair. Hypotheses on this target 7Epithelial barrier repairLipid peroxidation. Hypotheses on this target 7Lipid peroxidationSensory afferent activity. Hypotheses on this target 7Sensory afferent activityProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 5Calcium phosphate mineral growthInflammatory response. Hypotheses on this target 5Inflammatory responseTissue renewal timing. Hypotheses on this target 5Tissue renewal timingAntigen presentation. Hypotheses on this target 4Antigen presentationAntigen-receptor signaling. Hypotheses on this target 4Antigen-receptor signalingInflammation resolution. Hypotheses on this target 4Inflammation resolutionVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentDNA repair. Hypotheses on this target 2DNA repairEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationMechanical loading. Hypotheses on this target 2Mechanical loadingOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTranscription. Hypotheses on this target 2TranscriptionTranscription–replication conflicts. Hypotheses on this target 2Transcription–replication conflictsTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportUbiquitin-dependent proteasomal degradation. Hypotheses on this target 2Ubiquitin-dependent proteasomal degradationAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCardiovascular feedback regulation. Hypotheses on this target 1Cardiovascular feedback regulationCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle alignment. Hypotheses on this target 1Cell-cycle alignmentCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell-cycle restraint coordination. Hypotheses on this target 1Cell-cycle restraint coordinationCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentriole duplication. Hypotheses on this target 1Centriole duplicationCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCortisol inactivation. Hypotheses on this target 1Cortisol inactivationCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHeterotypic cell replacement. Hypotheses on this target 1Heterotypic cell replacementHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLactate-to-glucose recycling. Hypotheses on this target 1Lactate-to-glucose recyclingLipid-dependent receptor signaling. Hypotheses on this target 1Lipid-dependent receptor signalingLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal exocytosis. Hypotheses on this target 1Lysosomal exocytosisLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkNuclear-envelope rupture. Hypotheses on this target 1Nuclear-envelope ruptureNuclear rejuvenation. Hypotheses on this target 1Nuclear rejuvenationNutrient uptake and metabolism. Hypotheses on this target 1Nutrient uptake and metabolismOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismOxygen delivery. Hypotheses on this target 1Oxygen deliveryParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPathogen production. Hypotheses on this target 1Pathogen productionPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPotassium uptake. Hypotheses on this target 1Potassium uptakePreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRepair-initiation signaling. Hypotheses on this target 1Repair-initiation signalingRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSodium reabsorption. Hypotheses on this target 1Sodium reabsorptionSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Removing damaged cells could improve aging tissue while briefly weakening its protection against harmful microbes. The unexpected move is that this opening might create new dangerous through -induced genetic changes, rather than simply give existing dangerous cells more room to grow. That route is a proposal generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. An active microbial producer supplies a -damaging near an aging intestinal lining.
  2. cells help maintain a that limits the 's access to cells renewing the lining.
  3. Removal or changes the lining from functionally protective to more exposed during repair, even if apparent remains.
  4. Increased local exposure damages surviving cells and may leave new .
  5. Some acquired changes are proposed to cause sustained by , including after .
A picture for it

Replacing a worn window can improve a house while briefly letting rain reach the wiring. Closing the opening afterward does not necessarily undo damage that happened while it was exposed.

Where the picture breaks: Living have several protective functions, and exposed cells may die, recover or leave . The picture cannot establish that exposure produces an inherited change or that such a change causes .

  1. Master questionstep 01 of 04

    Radically slowing human aging is the overarching goal.

    Rests on: The supplied goal makes human aging the target; it does not specify a or establish that radical slowing is achievable.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Age-related damage may become entrenched when defective forms of gain an advantage.

    Rests on: The goal of slowing aging supplies a reason to investigate persistent damage, but does not itself explain why defective would gain an advantage.

    Assumption

    The pillar takes as given that an advantage enjoyed by defective can help make age-related damage persist; no supporting or finding is supplied at this stage.

  3. Gap questionstep 03 of 04

    Suppressing expanding groups of related , the cells that form tissue linings, might remove and allow dangerous cells to invade surrounding tissue. The question is how repeated repair distinguishes that loss of protection from beneficial removal of cells that function poorly.

    Rests on: The preceding pillar identifies defective as a possible source of persistent damage, but does not identify or explain how suppressing them would release .

    Leap

    The missing connection is why a population targeted as part of defective would also restrain dangerous , and how its removal would remove that restraint. This stage poses that possibility without supplying the connection.

  4. Hypothesisstep 04 of 04

    A could protect the intestinal lining by limiting exposure to that damage , the material carrying genetic information. Removing that protection might let surviving cells acquire that make their persistently .S1

    Rests on: The preceding question supplies the possibility of protective . S1, published in Gut microbes in 2023, reports that chemically induced disruption in mice brought microbes into direct contact with the colon lining; it does not establish increased delivery after removal in aging human tissue, new inherited changes in surviving cells, or caused by those changes.

    Supported by literature

What is carried, and what is not. One screened source, S1 in Gut microbes in 2023, speaks to the -to-contact part of the proposed sequence: disrupted allowed microbial contact in mice, without establishing the -removal in aging human tissue. None of the three crucial links—removal increasing , that exposure producing surviving cells with new inherited changes, and those changes causing sustained —is established by the supplied sources, individually or end to end.S1

Where the reasoning is carried by something unstated · 2
  • Goal pillar. The pillar takes as given that an advantage enjoyed by defective can help make age-related damage persist; no supporting or finding is supplied at this stage.
  • Gap question. The missing connection is why a population targeted as part of defective would also restrain dangerous , and how its removal would remove that restraint. This stage poses that possibility without supplying the connection. Establish the missing link before relying on this step.
How a result here could mislead · 3
  • More after exposure could reflect survival or expansion of an already dangerous population, rather than creation of a new one. A new genetic change found alongside expansion could also be incidental. What closes it: The design requires stored ancestral samples, explicit limits on detecting rare starting populations, and reconstruction of across repeated samples. After , must be compared in a shared undamaged environment, and introducing the nominated change into ancestral cells or correcting it in must test whether that change causes .
  • A difference between -producing and could arise from other differences in microbial behavior. Conversely, a negative result could mean that removal never increased , even though the producer was present. What closes it: The proposed matched microbial conditions remain an experimental target, not validated . Microbial growth, , attachment and proximity must be checked alongside local activity, —the ease with which substances cross the lining—and damage in surviving cells; equal microbial counts alone do not establish equal exposure.
  • Greater descendant production or a larger share of dangerous cells could be mistaken for greater . Removal-related injury, nutrients released from dead cells, or reduced by neighboring cells could increase growth without the proposed new genetic cause. What closes it: The design requires separate measurements of , population shares with their totals, recovered function and crossing of the , the supporting layer beneath the lining. Initial injury and dead-cell material must be matched as specified, while later -caused injury remains part of the overall effect; shared-environment tests and direct tests of the acquired genetic change are still needed to attribute to this route.

What would make this wrong. Within a tested setting containing a verified active producer and viable exposed cells, the proposed sequence would fail if removal did not increase , if increased exposure did not produce new inherited changes in surviving , or if the nominated acquired changes did not cause sustained . Evidence that came entirely from pre-existing dangerous populations or persisted independently of the acquired changes would also defeat attribution to this route in that setting. A would remain bounded by the tested exposure, observation period and ability to detect rare . The supplied specification gives no validated dose, observation period or causal genetic change, includes an omitted continuation, and supplies no gap verdict.

What it would change. If this held, removing poorly functioning cells as part of an effort to slow human aging would also require accounting for the protection those cells provide during repair. Better function after could coexist with a temporary increase in the creation of dangerous . Even a successful result in the proposed older-donor intestinal model would not establish that this route occurs across aging human tissues, that blocking it prevents cancer in people, or that it radically slows aging.

Sources read · 2

8 literature searches, 1 full text, 1 abstract-only; 2 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Partly answers it

Short-term mucosal disruption enables colibactin-producing E. coli to cause long-term perturbation of colonic homeostasis. · Gut microbes · 2023

“FISH analysis of the colon after five days of DSS treatment showed disruption of the mucus layer, with the microbiota in direct contact with the colonic epithelium ( ).”

Does not settle: The source does not establish that removal of a resident's barrier contribution increases the delivered colibactin dose in aging human mucosa, that exposed surviving renewing cells acquire new heritable lesions, or that such lesions causally confer sustained invasiveness on descendants. It studies DSS-induced mucus disruption in mice, not resident removal-to-repair.

S2BackgroundAbstract only

The merits of in vitro versus in vivo modeling in investigation of the immune system. · Environmental toxicology and pharmacology · 2006

“The hypotheses of well-designed in vitro experiments must also be tested in intact in vivo models to determine relevance and to discard artifactual findings secondary to the in vitro environment.”

Does not settle: This abstract does not establish that resident removal increases local genotoxin exposure, that exposure creates new heritable lesions in surviving renewing human mucosal cells, or that such lesions causally drive sustained invasion. It reports no relevant population, producer, toxin dose, timescale, barrier function, mutation endpoint, lineage outcome, or invasion experiment.

The gap this hypothesis explains

Two established results predict opposite outcomes, and both cannot be right.

Does suppressing expanding cell families in aging human linings promote or improve repeated repair?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

During human aging, can suppressing expanding accelerate dangerous by removing , and what distinguishes this from removal of genuinely across repeated repair?

What this question is asking

The question concerns growing families of related cells in the tissues that cover body surfaces and line organs during human aging. It asks whether suppressing those families could remove cells that restrain dangerous neighbors, allowing those neighbors to spread into surrounding tissue. It also asks how that outcome differs from removing cell families that actually damage tissue function through repeated cycles of injury and repair. The comparison is versus leaving the families in place, assessed together for , protection from neighboring cells, and tissue function over months to years. The question assumes that some expanding families provide protection and that expansion alone does not establish harmful behavior; the supplied sources do not establish that distinction in aging human tissues.

What the terms mean
Epithelium and epithelial cells
is tissue that covers body surfaces or lines organs; make up that tissue. These are the cells whose expanding families the question proposes suppressing.
Clone, cell family, and lineage
A is a family of cells descended from a common ancestor cell; refers to that and its . These terms describe relatedness, not whether the cells are healthy, harmful, or protective.
Clonal expansion
An increase in the number or tissue share of cells belonging to one family. Expansion alone does not specify what happens to tissue function or .
Suppression
Reducing a cell family's growth or abundance. The supplied question does not specify a method or establish that removes the family completely.
Aged human mosaic
An aging human tissue containing a mixture of cell families with different characteristics. The question asks how changing that mixture affects function and .
Cell competition and protective competitor
Cell competition describes interactions that affect which cells persist or expand alongside others. A protective competitor is a cell family whose presence restrains dangerous neighbors; that protective role is an assumption to evaluate here.
Ecological release
Expansion or spread that becomes possible after a restraining competitor is removed. In this question, it names the proposed causal link between suppressing one cell family and increased by another.
Invasion
Spread of cells into surrounding tissue beyond their previous location. It differs from simply increasing the number of cells within an existing tissue region.
Stroma and stromal signaling
Stroma is the supporting tissue around other tissue structures. means messages from that supporting tissue that influence nearby cells; the premise proposes that such messages can enhance .
Dysfunctional lineage
A cell family that impairs tissue work, appropriate control of growth, or the performance of specialized cell roles. It is a functional description, not a designation established merely by expansion.
Specialization, growth control, and repeated repair
means cells performing their particular tissue jobs; means regulation of when and how much cells multiply. Repeated repair means successive episodes of restoring damaged tissue, across which the question requires function to be maintained.
Adhesion
Attachment between cells. S4 reports reduced attachment alongside increased competition, without establishing the aging-related consequences of competitor removal.
Epithelial-to-mesenchymal transition
A change in which lining cells acquire characteristics associated with less tightly attached, more mobile cell states. The term covers a range of changes rather than a single all-or-nothing switch; S3 reports its induction, not the outcome asked about here.
Gene, genetic change, and protein
A gene is a stretch of inherited cellular information, and a genetic change is an alteration in that information. Proteins are molecules that carry out many cellular tasks; the supplied studies include removal of a gene and induction of a protein, which are different interventions from suppressing an expanding cell family.
Cell line and transplanted tumor
A cell line is a population of cells maintained for study outside its original tissue. A transplanted tumor is tumor tissue or tumor-forming cells placed into a recipient for study; neither system by itself establishes effects during human aging.
What the question takes for granted
Premise could not be checked
can constrain tumors, while can enhance , so suppressing expanding in aged may remove rather than genuinely .

The assumption concerns families of related cells in body coverings and organ linings, alongside the supporting tissue around them. It proposes that competition among the lining cells can restrain dangerous growth while messages from surrounding support cells can encourage . If that distinction holds during human aging, the consequences of suppressing a growing cell family would depend on what it does to its neighbors and to tissue function, rather than simply how much it expands.

The supplied evidence does not establish the combined premise in aging human tissues. S1 describes different patterns of altered-cell growth in different regions of mouse skin, without testing removal of . S4 reports reduced and increased competition after induction of a protein in cells surrounding a cancer, but does not establish that this competition protects against or that suppressing a competitor releases . S3 and S8 do not test that distinction either. This small set of background sources is too indirect to judge the premise; it does not refute it.S1S3S4S8

The same question asked without the part nothing read establishes:

  • During human aging, does suppressing expanding families of lining cells increase, decrease, or leave unchanged and tissue function across repeated repair?
  • What distinguishes expanding families of lining cells whose increases from those whose improves tissue function across repeated repair?
What turns on the answer
  • increases Under the proposed protective-competition , removes cells that restrain dangerous neighbors, allowing those neighbors to spread further into surrounding tissue. A reduction in the targeted family would then coexist with increased danger, so reduced expansion alone would not establish a beneficial outcome.
  • improves repair without increasing If the targeted family impairs tissue function, its could reduce that interference during subsequent repair. Improved function without increased would support a beneficial effect of in that setting, although it would not by itself establish the precise .
  • improves function but increases An expanding family could, within the question's proposed framework, impair tissue work while also restraining dangerous neighbors. Removing it could therefore improve repair and increase at the same time, making either measurement alone an incomplete account of the outcome.
  • changes neither outcome If neither nor tissue function changes, suppressing expansion would show no benefit or harm on those measured outcomes. That result alone would not establish whether the family had no relevant role or whether other cells maintained its effects.
Why it matters

The proposed causal chain begins with suppressing an expanding cell family, which changes which cells remain in the tissue. If that family restrains dangerous neighbors, removing it could remove a to their spread into surrounding tissue. If the family instead impairs normal tissue work, removing it could have a different consequence for repeated repair. Mistaking protective growth for harmful growth could therefore increase , while mistaking harmful growth for protection could preserve impaired tissue function. These are conditional consequences of the question's proposed , not outcomes demonstrated by the supplied sources.

What is already established

RL-1 can constrain tumors, while RL-1 can enhance ; human inflammatory lacks aging safety.

What would have to be true

Across months–years of , must not progressively impair , or function; is permissible.

What is missing

The in aged is unknown when protection, tissue function and are evaluated together.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

SCOUT 1 from , conditional: In an aging with a verified active , loss of a contribution during may increase the dose delivered to surviving . A subset might survive with newly acquired that causally confer sustained on their . This requires three distinct unverified links: removal increases local exposure, exposure creates surviving new , and those contribute causally to later . The protection here is of , not necessarily superior . Apparent alone does not establish , , or ; even may increase exposure, whereas extraction with rapid may not. -dependent of an already or , or , is a separate compatible explanation. Removing a could improve later while transiently increasing exposure. Preventing this channel could reduce the birth of new dangerous but need not change the SPV_9 of existing dangerous ; , and remain distinct. No general claim that every aging carries the required producer is made.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

Proposed : use a defined older-donor supporting documented microbial contact and repair, with , deeply characterized split across conditions. Cross , and controlled small-area removal with verified , and producer conditions plus . The matched pair is an experimental target: verify microbial growth, , , and proximity; equal bacterial counts are not equal . Match , non- injury, starting , nutrients, initial and ; -induced corpse release is not in the . Measure and local activity/contact over time and do not force -mediated injury equal, because it lies on the proposed . First establish whether removal actually increases and /damage in surviving cells. If it does, follow , repeated samples and to nominate acquired after exposure and before , reporting rather than claiming every rare pre-existing was absent. A new or plus expansion is insufficient. After , compare in a shared uninjured and ; reconstruct a nominated in the appropriate or correct it in the descendant, with matched , to test causal behavior and possible cooperation with pre-existing . Under the hypothesis, specific interruption reduces the , and restoration of verified is predicted to restore its population-level contribution under a viable , not the identical or descendant in every . alone can also reflect or growth of pre-existing ; and distinguish these routes. or should lack this -mediated new- component, while other release can persist. A bounds the tested dose/time and detectable , not all late events. Measure , with , mature and separately. -dependent without required supports a contribution and can coexist with . Additional required and bounded interpretations: Measure , activity/contact, /damage, and surviving descendant in under matched and conditions. Bound pre-existing and require separate before predicting ; current cannot establish past exposure. Compare , absolute growth and in matched normal and tumor contexts with recorded and . Independently test and mature/ function; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track , direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional and mature/ outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native and does not establish absence of new merely because none were intended. Compare , and the specified removal procedure using delivered activity/contact, measures and surviving--cell damage. Proceed to the only if that first link is supported in the proposed model; absence under rapid bounds that procedure, not all removal. Preserve , , and . Test nominated new changes in the relevant , with existing characterized, and require a causal contribution to sustained anatomical after in a justified common rather than or alone. Across compare and of surviving , with uncertainty, , and adequate recorded. Restoration means of the within a justified ; a finite unmatched is not , and no universal is asserted. Report both and with their distinct intervention conditions; track all initial , death and surviving , then report as such. Preserve the in comparisons and use rather than treating as . Where indicated, test justified and characterized with matched . Retain the and test sustained in a shared justified for the original tissue. enabled only by an artificial does not establish consequential caused by removal in aging tissue. Current finding-specific qualification: restoration remains a , with distinct per initial , per exposure and conditional on survival. A is a separate only if the is feasible and does not independently alter delivered , or relevant repair functions; feasibility is not established. and report the probability of at least one per starting , absolute counts per initial , and any with its and uncertainty; separately and follow all initial including . Validate any for exposure and ; if validation fails, omit its while retaining the with -induced injury, death and feeding intact. Validate and delivery; alone still does not distinguish from .

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies measurable reductions, restoration and absence of a toxin-mediated acquired-lesion component under stated conditions. No rival prediction is supplied. The chunk states an observable invasion outcome conditional on whether new causal lesions are required, and an explicit condition for supporting resident protection. These go beyond intentions to measure or investigate. No rival prediction is supplied. The chunk states a conditional prediction of distributional recovery under restoration and explicitly limits what would count as falsification. No rival prediction is supplied. The supplied chunk states a limitation on causal interpretation but predicts no observable outcome, comparison, or rejection condition. A paper already fetched for this hypothesis bears on it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

A contained is conceptually testable; no validated , exposure dose, , or causal is supplied. Begin with and surviving-cell injury before attempting a long -to- chain. Deep sampling and phylogeny constrain but cannot eliminate rare pre-existing ; , and strengthen . If function or cannot be established, report or only and leave new--mediated unresolved. No deliberate human or is proposed.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

Proposed : use a defined older-donor supporting documented microbial contact and repair, with , deeply characterized split across conditions. Cross , and controlled small-area removal with verified , and producer conditions plus . The matched pair is an experimental target: verify microbial growth, , , and proximity; equal bacterial counts are not equal . Match , non- injury, starting , nutrients, initial and ; -induced corpse release is not in the . Measure and local activity/contact over time and do not force -mediated injury equal, because it lies on the proposed . First establish whether removal actually increases and /damage in surviving cells. If it does, follow , repeated samples and to nominate acquired after exposure and before , reporting rather than claiming every rare pre-existing was absent. A new or plus expansion is insufficient. After , compare in a shared uninjured and ; reconstruct a nominated in the appropriate or correct it in the descendant, with matched , to test causal behavior and possible cooperation with pre-existing . Under the hypothesis, specific interruption reduces the , and restoration of verified is predicted to restore its population-level contribution under a viable , not the identical or descendant in every . alone can also reflect or growth of pre-existing ; and distinguish these routes. or should lack this -mediated new- component, while other release can persist. A bounds the tested dose/time and detectable , not all late events. Measure , with , mature and separately. -dependent without required supports a contribution and can coexist with . Additional required and bounded interpretations: Measure , activity/contact, /damage, and surviving descendant in under matched and conditions. Bound pre-existing and require separate before predicting ; current cannot establish past exposure. Compare , absolute growth and in matched normal and tumor contexts with recorded and . Independently test and mature/ function; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track , direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional and mature/ outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native and does not establish absence of new merely because none were intended. Compare , and the specified removal procedure using delivered activity/contact, measures and surviving--cell damage. Proceed to the only if that first link is supported in the proposed model; absence under rapid bounds that procedure, not all removal. Preserve , , and . Test nominated new changes in the relevant , with existing characterized, and require a causal contribution to sustained anatomical after in a justified common rather than or alone. Across compare and of surviving , with uncertainty, , and adequate recorded. Restoration means of the within a justified ; a finite unmatched is not , and no universal is asserted. Report both and with their distinct intervention conditions; track all initial , death and surviving , then report as such. Preserve the in comparisons and use rather than treating as . Where indicated, test justified and characterized with matched . Retain the and test sustained in a shared justified for the original tissue. enabled only by an artificial does not establish consequential caused by removal in aging tissue. Current finding-specific qualification: restoration remains a , with distinct per initial , per exposure and conditional on survival. A is a separate only if the is feasible and does not independently alter delivered , or relevant repair functions; feasibility is not established. and report the probability of at least one per starting , absolute counts per initial , and any with its and uncertainty; separately and follow all initial including . Validate any for exposure and ; if validation fails, omit its while retaining the with -induced injury, death and feeding intact. Validate and delivery; alone still does not distinguish from .

  • What would separate them

    Cell fusion may restore growth control through resident genes in aging epithelial tissue predicts: Proposed : begin in older-donor of one specified , with traceable /invader , measured local contacts, successful , nutrient delivery, and . First two viable becoming one viable , then establish , , / and subsequent ; exclude , , undegraded , or and . Quantify and whether and the restrained could account for the ; an undetected rare event gives a . Authentic must precede , but a is loss of a nominated functional within an established followed by release of , and followed by restored restraint, with matched , history and generic , measuring -dependent changes without . Compare appropriate to separate from generic extra- or stress. If identity remains unknown, report only. After that, a validated should reduce new protective formation and increase viable invader-derived output relative to , provided , , , , , nutrient access and function remain comparable. Test a new separately from already formed . viable should retain only the -attributable protection within the window where actual encounters, and mature function persist. Track late , , mature contribution and independently of and cell number. A selective with adequate limits the proposed contribution in this setting; generic favors a . can reveal an additional contribution, including retained , and geometry; they do not eliminate unless validated / contrasts add no effect within those . Additional required and bounded interpretations: Compare , absolute growth and in matched normal and tumor contexts with recorded and . Independently test and mature/ function; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track , direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional and mature/ outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native and does not establish absence of new merely because none were intended. First calibrate and spontaneous two-parent-to-one viable events, phase and , and follow viability and before attempting tests. If none are detected, give a tissue/window/-dependent upper bound; missing or insufficiently detectable events leave wider-subset support unknown. Conditional on viable , of the nominated deficient function should reinstate -mediated restraint, whereas matched controls and test or . Measure changes as possible , distinguishing them from generic stress. If , viability or defect identity cannot be established, report -associated or unresolved identification rather than rejection or proven . Estimate per time and their viable descendant output avoided per event with uncertainty, including unfused invaders and . Integrate these contributions through repairs and compare with the observed ; sustained arrested- accumulation alone cannot account for a . Before the contrast, and a window based on actual local contacts, incidence, and mature/ function, then independently validate those conditions during the comparison. Retained -attributable protection in that window does not predict months–years of adequate replenishment; follow repeated repair separately and call the isolated comparison inconclusive if its controls fail. Compare , persistence/ and mature tissue contribution across successive repairs, with late chromosome and tracking. Report the observed and remaining explicitly; no early or arbitrary finite certifies long-term safety. Current finding-specific qualification: The avoided output of a fused invader is an unobserved : an arbitrary unfused invader need not be because may select contact histories and cell states. A formation-mediated field contribution remains conditional on a justified comparable-/history contrast, not on . Constrain avoided descendant output using comparable and pre-event contact/state histories together with selective formation loss/; report residual uncertainty and if comparability fails. Integrate , output, , late and unfused over the same . No event frequency or quantitative protective effect is supplied.

  • What would separate them

    Resident daughter cells may restrain epithelial invaders by replacing their renewing positions predicts: Proposed : in a older-donor mosaic of one site, track a complete : , and , , extrusion direction, death, vacancies and actual replacement of viable invader . Keep invader , initial composition, , nutrients and comparable and measure local , density, cell size, and . First test whether gross J_R predicts directly observed h_RI at all. Then reversibly alter output with a and during the measured window before mature function or diverges, with direct . If the operates, a reduction in successful h_RI should reduce and increase absolute renewing-invader growth by the when other rates are unchanged; restoring h_RI with competent should restore that component of restraint. Equal J_R alone does not establish equivalent replacements, and no -count-independent claim is made without equivalent contacts, and function. Estimate from , predict , and vary geometry explicitly rather than absorbing every result into kappa_R. Gross production changes with no h_RI change and no growth effect favor a over a transferable . Coupled mechanical and replacement effects support and limit an independent . Measure and independently; a lower g_I cannot compensate for their deterioration. If or feeding interruption removes an while h_RI stays low, this limits loss as a sufficient or dominant cause only when invader growth capacity is preserved. Nutrients can increase lambda_I or survival enough to overcome high h_RI without disproving . Cross that preserve both and allow events; effects may alter h_RI or other rates and can coexist, while a selective h_RI null bounds this contribution. Report SPV_9 with growth and anatomical crossing separately. Additional required and bounded interpretations: Before observing held-out , estimate on other repairs, then integrate their predicted and propagate , and . Compare predicted absolute I and separate tissue with observations. A failed limits that reduction, not the possibility of ; from the same outcome episode is bookkeeping, not . Follow P_R(t), , D_R survival/lifespan, tissue-specific mature function, and reserve available at the next repair jointly. Integrate and loss over time; a lower renewing-invader growth rate or higher J_R does not establish beneficial aging or adequate . Track , , and mature survival separately; audit / and include their or restrict the model to a justified . Estimate time/geometry-conditioned rates and integrate held-out repair trajectories with uncertainty, preserving specialized function as an independent outcome. Directly count gross per measured area/time and separately follow which reach and causally replace viable invader positions. Record changing area and boundaries; compare J_R with the event-resolved hazard in held-out geometry/time , allowing no relation or changing kappa_R. Freeze training-derived time/geometry relationships and before , including and repair-stage changes; use observable starting state and prespecified inputs. Recounting all held-out afterward checks accounting only. If no useful stable relation survives, retain event-caused conditionally and reject or bound that , not replace its . invader-derived membership and count each viable descendant once in a , track renewing and and dynamics, and report SPV_9 per year separately from absolute growth and crossing. Check observed count consistency and uncertainty; changing fractions or counts alone cannot establish or whole-human aging benefit. Compare , absolute growth and in matched normal and tumor contexts with recorded and . Independently test and mature/ function; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track , direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional and mature/ outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native and does not establish absence of new merely because none were intended. Use time-resolved boundary imaging plus selective output/ perturbation and , comparing the ordering of , and invader exit. uncertain-order cases and bound their influence; preserved area or gross J_R alone cannot identify replacement causation. Calibrate observation and missed events; report growth bounds under plausible assignments of ambiguous events without allocating them to fit the equation. Track displaced as viable differentiated, basally displaced, dead or unresolved separately: loss from the is not automatically loss of the or anatomical safety. Current finding-specific qualification: The applies to a or justified with and represented flows; it is not a realized or an . For random , dE[I_s]/dt=E[g_s I_s]+E[], and E[g_s I_s] generally differs from E[g_s]E[I_s]. A requires independent justification. and validate the on training repairs or integrate an explicit ; propagate event, rate and into held-out and outcome . Report and separately, without replacing the already defined by the . Compare equally prespecified contact/occupancy models. Match ; measure caused by daughter as part of its total effect instead of clamping that mediator. A failed or limits that reduction, not event-caused .

  • What would separate them

    Dead resident cells may feed invasive lineages during epithelial repair predicts: Proposed : in a defined older-donor mosaic with a barcoded pre-existing , initially exclude microbes and . Compare , , killing with retained and physical extraction, recording local , successful , mature function, , nutrient delivery, and . , , then measure the amount, and released, cleared and reaching invaders. Trace through into newly synthesized invader and, for survival/maintenance, quantify and energetic use; exclude residual /, , and . Add only in separate to distinguish . Quantify absolute , deaths, net newly produced and events. Use carbon/nitrogen or -relevant , with inputs, recovered and , to ask whether accessible and its measured plausibly account for extra output; a need not supply most , but its necessity and quantitative capacity must be shown. Test measured under -supporting, nutrient/ and conditions; dependence manufactured by starvation does not establish an ordinary-human route. After identifying a candidate , use invader-specific with and demonstrated loss of relevant , the , and compare equally injured invaders supplied with non-corpse nutrients. fitness alone cannot exclude a general repair-stress or effect, and one block is not a complete . Under the hypothesis, selective loss of reduces the extra production/survival component and its restoration it. at measured is supplementary: separately interrupt versus where feasible and test alternative to distinguish instructions from feeding. If drives extra growth despite adequately verified loss of , the feeding contribution is bounded; if selective separation is impossible, plus growth does not establish nutrition. High- or can consume the or suppress fed invaders, so restored restraint does not disprove feeding. Measure actual uptake and birth/loss terms in such ; may separately determine crossing. alone does not exclude nutrition, and alone does not exclude . Additional required and bounded interpretations: For the survival branch extend -relevant to , , and energetic/maintenance use, while separating contamination and indirect macrophage recycling. Couple measured to absolute survival/death and selective loss/; absence of retained alone cannot exclude , and catabolic alone cannot establish its causal benefit. Bound accessible amount, uptake rate and plausible output supported using the measured requirement/ and uncertainty; test graded availability with alternative and -selective loss/ when feasible. Do not equate with causal contribution or claim a numerical capacity absent measurements. Compare , absolute growth and in matched normal and tumor contexts with recorded and . Independently test and mature/ function; a alone neither validates any native candidate nor predicts older-human cancer prevention. In the same older-donor compare retained versus removed with matched initial wounding and adequate , and separately vary immune presence when feasible. Track , direct losses, , and mature function. protection is supported only as a measured contribution after removal-induced injury alternatives are tested; behavior alone does not establish irrelevance. Compare survival and under recorded inflammatory exposure versus comparable noninflamed conditions, with functional and mature/ outcomes. track cancer outcomes separately. Any -context resistance prediction does not imply an age-only benefit or make a universally protective. vary defined and within a recorded and matched repair context; measure actual , , , and wound strength separately. A contribution can coexist with all four native and does not establish absence of new merely because none were intended. Quantify release, delivery, uptake and use versus viable/suppressed- , and test whether a limiting material input causes extra survival or production after controlling independent while allowing to vary. Equivalent dead mass from another predicts equivalence only when species, composition, , and local availability are matched. Demonstrate loss of the relevant , intact matched-injury responses and alternative-nutrition growth, and -specific . If or inseparable prevents these controls, report transfer plus and bounds, not proven ; a single null perturbation does not reject the . Measure local release, availability, uptake and output over an explicitly justified delivery/ range anchored to the chosen tissue once such data exist. Report the range as unvalidated until measured. An arm isolates direct transfer; separately add /recycling and record net effects before making any inference. Current finding-specific qualification: Material feeding can cause . Preserving independent in the must not mean clamping caused by restored limiting material or energy. The rival is instruction independent of that limiting material function, not every response to nutrition. Where selective separation is feasible, compare material-use loss and or suitable nutrient restoration while preserving independent instructive exposure and matched-injury/alternative-nutrition competence, allowing nutrient-state responses to vary. Attribute and to viable invaders with the existing , and separate- controls. If material and instructive roles cannot be separated, report transfer, and -specific quantitative bounds rather than proven .

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteA paper already fetched for this hypothesis bears on it

What it would take to refute it. 1 paper(s) already retrieved for this hypothesis carry its prediction’s terms. Reading them comes before running anything. Already retrieved: 2020 ACVIM Forum On Demand Research Abstract Program..

6 papers retrieved around this hypothesis
  • UEG Week 2024 Moderated Posterseuropepmc:PMC:PMC11471002 · unavailable · 0 characters stored
  • 2020 ACVIM Forum On Demand Research Abstract Program.PMID 33037851 · full_text · 886,057 characters stored
  • Publication Onlyeuropepmc:PMC:PMC13254489 · unavailable · 0 characters stored
  • 2026 ACVIM Forum Research Abstract Program June 10 – October 31, 2026 Seattle, Washingtoneuropepmc:PMC:PMC13540732 · unavailable · 0 characters stored
  • UEG Week 2024 Oral Presentationseuropepmc:PMC:PMC11470993 · unavailable · 0 characters stored
  • Abstracts from the 57th European Society of Human Genetics (ESHG) Conference: Hybrid Posterseuropepmc:PMC:PMC11627200 · unavailable · 0 characters stored

0 citation handles extracted; 1 Europe PMC search run; 8 records examined; 6 sources stored for enrichment, 1 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.